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Objectives: We sought to establish a novel method to generate nano-sized carbon black particles (nano-CBPs) with an average 
size smaller than 100 nm for examining the inhalation exposure risks of experimental rats. We also tested the effect of nano-CBPs 
on the pulmonary and circulatory systems.
Methods: We used chemical vapor deposition (CVD) without the addition of any additives to generate nano-CBPs with a particle 
size (electrical mobility diameter) of less than 100nm to examine the effects of inhalation exposure. Nano­CBPs were applied to 
a nose-only inhalation chamber system for studying the inhalation toxicity in rats. The effect on the lungs and circulatory system 
was determined according to the degree of inflammation as quantified by bronchoalveolar lavage fluid (BALF). The functional 
alteration of the hemostatic and vasomotor activities was measured by plasma coagulation, platelet activity, contraction and re-
laxation of blood vessels.
Results: Nano­CBPs were generated in the range of 83.3­87.9 nm.  Rats were exposed for 4 hour/day, 5 days/week for 4 weeks to 
4.2 × 106, 6.2 × 105, and 1.3 × 105 particles/cm3. Exposure of nano­CBPs by inhalation resulted in minimal pulmonary inflamma-
tion and did not appear to damage the lung tissue. In addition, there was no significant effect on blood functions, such as plasma 
coagulation and platelet aggregation, or on vasomotor function.
Conclusion: We successfully generated nano­CBPs in the range of 83.3­87.9 nm at a maximum concentration of 4.2 × 106 par-
ticles/cm3 in a nose-only inhalation chamber system. This reliable method can be useful to investigate the biological and toxico-
logical effects of inhalation exposure to nano-CBPs on experimental rats.
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 Introduction
Carbon black (CB; CAS No. 1333-86-4) is virtually pure el-
emental carbon in the form of colloidal particles that are pro-
duced by incomplete combustion or thermal decomposition of 
gaseous or liquid hydrocarbons under controlled conditions. 
Current worldwide production is about 8.1 million metric tons 
per year, which ranks as one of the top 50 industrial chemicals 
manufactured worldwide. Approximately 90% of CB is used in 
rubber applications, 9% as a pigment, and the remaining 1% as 
an essential ingredient in hundreds of diverse applications [1].
Ten workplaces in Korea with 168 workers produce ap-
proximately 282,000 tons per year of CB (the Korea Occupa-
tional Safety and Health Agency). Additionally, more than 
2,100 workers in 379 workplaces are involved in various manu-
facturing industries that consume approximately 1,823,000 
tons of  CB as the raw material [2]. Therefore, occupational 
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exposure of CB may be a health problem to Korean workers. 
As an ultrafine particle (UFP), CB can disperse in ambient 
conditions and be readily exposed by inhalation in workplaces. 
Therefore, the respiratory system serves as the primary target 
of  CB exposure. The inhalation of  particulate matters (PM) 
primarily leads to inflammation in the pulmonary system and, 
subsequently, spreads to systemic inflammation, which is the 
general mechanism for PM-induced toxicity [3]. UFPs, gener-
ally smaller than 100 nm in size, can even enter into the circula-
tory system directly, leading to diverse systemic problems such 
as cardiovascular toxicities and neurological disorders [4]. Re-
cently, UFPs were demonstrated to exhibit general properties in 
biological systems to some extent, regardless of their chemical 
composition, e.g., the induction of inflammation, penetration 
of biological membranes, and generation of free radicals/oxi-
dative stress [5]. These suggest that the biological effects of CB 
may not be different from those of other UFPs.  
In this study, we examined the first line effect of  nano-
sized CB particles (nano-CBPs) in experimental animal mod-
els. To test the biological effect of nano-CBPs, we established 
the methods to generate CBPs smaller than 100 nm by chemi-
cal vapor deposition (CVD). We exposed Sprague-Dawley rats 
to the resulting particles via a nose-only inhalation chamber. 
Pathological analysis was performed with lung tissue. Inflam-
matory cytokines were analyzed with bronchoalveolar lavage 
fluid (BALF) to test whether nano-CBPs induce inflammation. 
In addition, plasma coagulability, platelet aggregation and va-
somotor function were examined to evaluate the cardiovascular 
consequence of nano-CBP exposure.
Materials and Methods
Chemicals and reagents 
Hematologic reagents for prothrombin time (PT) and activated 
partial thromboplastin time (aPTT) measurement were from 
Fisher Diagnostics (Middletown, VA, USA).  ELISA kits for 
interleukin-6 (IL-6), IL-1b, IL-4, IL-10, tumor necrosis factor-α 
(TNF-α), and interferon-gamma (IFN-g) were supplied by BD 
Biosciences (San Diego, CA, USA). Thrombin, phenylephrine 
and serotonin were obtained from Sigma-Aldrich (St. Louis, 
MO, USA). All other chemicals used were of the highest purity 
available and purchased from standard suppliers.
Animals
Specific pathogen-free 5-week-old Sprague-Dawley rats were 
purchased from Central Lab Animal Inc. (Seoul, Korea) and 
underwent 4-week quarantine and acclimatization before use. 
The rats were housed in a room maintained at a temperature 
of 22 ± 3oC and a relative humidity of 50 ± 20% with artificial 
lighting from 8 AM to 8 PM and with 12-15 air changes per 
hour. The rats were housed in polycarbonate cages and allowed 
sterilized tap water and commercial rodent chow (LabDiet 
5053, PMI Nutrition, St. Louis, MO, USA) ad libitum. The rat 
studies were approved by an animal ethics committee to ensure 
appropriate animal care before the rats were obtained for re-
search.
Dispersion and characterization of CB with airborne 
CB generation system
The ethylene used as a precursor was of  commercial grade 
(99.999%, RIGAS, Daejeon, Korea). Argon (99.999%, Deoky-
ang Energen Co., Seosan, Korea) was used as the carrier gas. A 
picture of the CVD equipment is shown in Fig. 1. The reactor 
consisted of a vertical quartz tube (D 22 × 1,000 mm) heated 
by an electric resistance furnace. The temperature was con-
trolled and monitored by a thermocouple. The reactant gases 
(C2H4 and Ar) were fed into the reactor through electronic mass 
flow controllers. The effluent gases were tripped by a water 
cooling system, and effluent gases and CB were diluted in the 
mixing chamber with air. The flow rates of ethylene and argon 
were 10 mL/min and 1,300 mL/min, respectively. The furnace 
temperature was adjusted to 900oC.
Particle size analysis by scanning nano-particle 
spectrometer and measurement of the particles’ 
weight concentration
Measurements were performed with a scanning nano-particle 
spectrometer (SNPS; HCT, Icheon, Korea). The SNPS system 
Fig. 1. Picture of the chemical vapor deposition equipment.
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comprised a condensation particle counter (HCT, Icheon, 
Korea), which measured the particle count concentration. The 
instrument measured particles in the size range from 7-300 nm. 
A Gilian air sampler (Sensidyne Inc., Clearwater, FL, USA) 
with mixed cellulose ester membrane filter (37 mm, 0.2 µm) 
was used to measure the weight concentration of  CBP.  Air 
was sampled at a rate of 2.0 liter/min in the highest nose-only 
inhalation chamber.
Nose-only inhalation chamber for CB
Total flow rates (100 L/min) were supplied to 4 nose-only 
inhalation chambers. The flow rate was considered sufficient 
for the maximum number of  rodents (1.0 L/min/rat) and to 
monitor the particle concentration. The nose-only inhalation 
chamber for CB is shown in Fig. 2. The Sprague-Dawley rats 
were exposed to CB for 4 hour/day, 5 days/week for 4 weeks, 
after which they were sacrificed on the next day.
Analysis of BALF
The rats were euthanized with isoflurane (Ilsung Pharm, Seoul, 
Korea). A tracheal cannula was inserted and BAL was per-
formed 10 times through the cannula using 3 mL calcium- and 
magnesium-free, phosphate buffer solution, pH 7.4. The induc-
tion of inflammation was assessed by analyzing the inflamma-
tory cytokines in BALF
Plasma coagulation test 
Plasma coagulability was evaluated by PT and aPTT, which 
were measured with a Coagulator2 coagulation analyzer 
(Behnk Elektronik, Norderstedt, Germany) using thromboplas-
tin-D or CaCl2 and APTT-XL reagents (Fisher Diagnostics), 
respectively, according to the manufacturer’s instructions.
Platelet function analysis
Ex-vivo platelet aggregation study was performed with a 
4-channel aggregometer (Chrono-log, Havertown, PA, USA). 
Platelet-rich plasma (PRP) was isolated from CB-exposed rats, 
as described previously [6]. PRP was preincubated for 5 min 
at 37oC, and then 5-8 unit/mL thrombin or 20 g/mL collagen 
was added to induce aggregation.
Assessment of vasomotor function 
The rats were sacrificed by decapitation and then exsangui-
nated. We carefully isolated the thoracic aorta and cut it into 
ring segments. The prepared aortic rings were mounted in four-
channel organ baths filled with Krebs-Ringer solution (115.5 
mM NaCl, 4.6 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2.5 
mM CaCl2, 25.0 mM NaHCO3, and 11.1 mM glucose, pH 7.4). 
The organ bath was continuously gassed with 95% O2/5% CO2 
and maintained at 37oC. The rings were stretched gradually to 
an optimal resting tension of 2 g and equilibrated for 30 min. 
The change in tension was measured isometrically with Grass 
FT03 force transducers (Grass Instrument Co., Quincy, MA, 
USA) and recorded using the PowerLab 8/30 data acquisition 
system. Data were analyzed with the LabChart pro computer 
program (AD Instruments, Australia).
Statistical analysis
The means and standard deviation of  the means were calcu-
lated for all experiment groups.  The data were subjected to one 
way analysis of  variance, followed by Dunnett’s test to deter-
mine significant difference from the control. Statistical analyses 
were performed using SigmaStat software (Version 3.5, Systat 
Software, San Jose, CA, USA). In all cases, p-value of < 0.05 
was used to determine significance.
Fig. 2. Nose­only inhalation chamber (A), Scanning Nano­particle Spectrometer and Condensation Particle Counter (B).
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Results
Generation and characterization of nano-sized 
carbon black particles (nano-CBPs)
Ultrafine CB was generated by gas phase CVD and the char-
acteristics of  the dispersed particles were investigated. We 
established aerosol generator equipped with quart tube, and 
dispersed nano-CBPs at concentrations of 104, 105 and 106 par-
ticle/cm3 for low, middle, and high levels of exposure, respec-
tively. We thus obtained nano-CBPs with electrical mobility di-
ameters of 86.5 ± 1.41, 83.3 ± 1.46 and 87.9 ± 1.47 nm, which 
were quite comparable in size, for each level of  exposure, re-
spectively.  The number concentration was 4.2 × 106, 6.2 × 105 
and 1.3 × 105 particle/cm3 for high, middle or low levels of ex-
posure, and the specific surface area was 1.4 × 1011, 2.7 × 1010 
and 1.1 × 1010 nm2/cm3, respectively (Table 1). Approximately 
61% of particles were smaller than 100 nm (Table 2). The par-
ticle morphology was examined with transmission electron 
microscopy image analysis, which exhibited a mixed presence 
of  individual particles and an aciniform of small aggregates, 
which is the typical shape mixture of CB (Fig. 3). These results 
suggest that nano-CBPs were obtained successfully as intended 
with the gas phase CVD method.
Effect of nano-CBP exposure on pulmonary 
inflammation
Rats were exposed to nano-CBPs for 4 weeks and the effects 
on the lungs were examined. All the rats gained weight steadily 
during the experiment, and no significant difference was ob-
Table 1. Distribution of carbon black particles (mean ± standard 
deviation)
Group
Diameter 
(nm)*
Number
(particles/cm3)
Surface
(nm2/cm3)
High 86.5 (1.41) 4.2 × 106 ± 9.9 × 105 1.4 × 1011± 8.8 × 1010
Middle 83.3 (1.46) 6.2 × 105 ± 4.2 × 105 2.7 × 1010 ± 7.7 × 1010
Low 87.9 (1.47) 1.3 × 105 ± 2.8 × 105 1.1 × 1010 ± 5.7 × 1010
*GM (GSD).
Fig. 3. Distribution of CB (A) and TEM analysis of CB with TEM (B). CB: carbon black, TEM: transmission electron microscopy.
Fig. 4. Body weight changes of rats exposed to carbon black.
Table 2. Size distribution of carbon black particles
Groups
Diameter (nm)
< 50 50-100 ≥ 100
Average 6.7% 54.5% 38.8%
High 5.7% 53.6% 40.7%
Middle 7.4% 56.5% 36.2%
Low 6.9% 53.5% 39.6%
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served among the groups (Fig. 4). At the end of  the experi-
ment, the weight of the major organs (lung, kidney and heart) 
did not differ significantly among the treated groups (Table 3).
To test if  inhalation exposure to nano-CBPs damages the 
lung tissue, BALF was prepared, and albumin and lactate dehy-
drogenase (LDH) leakage were measured. However, no detect-
able increase was observed in either albumin or LDH level (Ta-
ble 4). Consistent with these results, no pathological symptom 
was observed in the histological analysis of the lungs. Pulmo-
nary inflammation was examined by analysis of inflammatory 
cytokines in BALF. As shown in Table 5, most of the samples, 
including IL-1b, IL-4, IL-6, TNF-α and INF-g, exhibited little 
change in levels. However, IL-10 level was significantly elevated 
in BALF from nano-CBP-exposed rats, and this elevation was 
CB concentration-dependent (Table 5). These results suggest 
that exposure of  nano-CBPs by inhalation does not damage 
the lung tissue and only induces minimal inflammation in the 
respiratory system.
Effect of nano-CBP exposure on blood and 
vasomotor function
Based on the reports that nano-CBPs are capable of enter-
ing the circulatory system and causing circulatory disorders, we 
evaluated the plasma coagulability and platelet aggregability of 
blood from rats exposed to nano-CBPs. Plasma coagulability 
was assessed with PT and aPTT measurements. Four-week ex-
posure to nano-CBPs did not affect PT. However, aPTT tended 
to increase in the nano-CBP-exposed groups and this increase 
was dependent on the carbon concentration but was not statis-
tically significant (Fig. 5).
The effect of nano-CBP exposure on platelet activity was 
examined by aggregation study. PRP was isolated from the 
blood and the aggregation was induced with 20 µg/mL col-
lagen or 5-8 U/mL thrombin. However, the platelet reactivity 
of the rats exposed to these agonists was not different from that 
of the control group (Fig. 6). The blood cell numbers, including 
red blood cells, white blood cells and platelets, showed no sig-
nificant difference among the treated groups (Table 6). These 
results suggest that the respiratory exposure of nano-CBPs does 
not affect the blood cell count and has only a minimal effect on 
blood functions such as plasma coagulation and platelet aggre-
gation.
To examine the effect of  CB on vascular function, we 
tested the response of the aorta to vasoconstrictors and vasore-
laxant. The aortic rings were isolated from the thoracic aorta 
and the vasomotor function was tested with a physiometer. The 
aortas from all experimental groups exhibited normal constric-
tion to serotonin and phenylephrine and relaxation to acetyl-
choline and there was no significant difference among groups, 
suggesting that nano-CBPs did not affect vasomotor function 
(Fig. 7).
Discussion
The aim of this study was to establish a novel method to gener-
ate nano-CBPs with an average size smaller than 100 nm for 
examining the inhalation exposure risks of experimental rats. 
We tested the effect of nano-CBPs generated by this method on 
the lungs and circulatory system. We generated 83.3-87.9 nm 
nano-CBPs up to a concentration of  4.2 × 106 particles/cm3 
and successfully exposed experimental rats to these particles in 
a nose-only inhalation chamber. Inhalation-exposure of nano-
CBPs resulted in only minimal pulmonary inflammation, did 
Table 3. Relative organ weight in rats of the exposure groups
Organ Control Low Middle High
Lung left 0.10 ± 0.004 0.11 ± 0.006 0.10 ± 0.001 0.10 ± 0.011
Lung right 0.20 ± 0.004 0.20 ± 0.017 0.19 ± 0.003 0.18 ± 0.017
Kidney left 0.29 ± 0.013 0.30 ± 0.021 0.31 ± 0.019 0.31 ± 0.015
Kidney right 0.29 ± 0.024 0.30 ± 0.015 0.31 ± 0.027 0.31 ± 0.020
Heart 0.28 ± 0.015 0.28 ± 0.017 0.28 ± 0.016 0.27 ± 0.014
All values are expressed as mean ± standard deviation (%).
Table 4. Bronchoalveolar lavage fluid biochemical values in rats 
of the exposure groups
Control Low Middle High
ALB 1.24 × 10
-3 ± 
1.39 × 10-3
0.98 × 10-3 ± 
0.87 × 10-3
1.85 × 10-3 ± 
1.07 × 10-3
2.14 × 10-3 ± 
2.31 × 10-3
LDH 8.02 ± 3.22 22.00 ± 19.44 11.80 ± 13.23 21.04 ± 15.87
All values are expressed as mean ± standard deviation.
ALB: albumin (mg/dl), LDH: lactate dehydrogenase (IU/l), n = 5.
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not damage the lung tissue, and did not significantly affect the 
blood functions such as plasma coagulation, platelet aggrega-
tion and vasomotor function. These study results suggest that 
subacute inhalation-exposure of  nano-CBPs up to about 106 
Fig. 5. Effect of carbon black on plasma coagulation in rats of the exposure groups. PT: prothrombin time, aPTT: activated partial thromboplastin 
time, EC: control, EL: low, EM: middle, EH: high. n = 5.
particles/cm3 does not critically affect the tested pulmonary 
and circulatory systems.
We intended to expose the rats to a higher concentration 
than 106 particle/cm3 to test the intoxication of nano-CBPs, but 
Table 5. Cytokine assay result in bronchoalveolar lavage fluid of standard deviation male rats exposed to carbon black (pg/mL)
Cytokine
Concentration of carbon black
Control Low Middle High
IFN-g 5,161.09 ± 86.87   5,163.54 ± 185.13 5,188.06 ± 190.92 4,937.95 ± 277.23
IL-1b   1,394.03 ± 216.07   1,536.36 ± 182.82      1,279 ± 357.14 1,407.68 ± 227.37
IL-4    14.76 ± 3.61    18.27 ± 3.47  19.51 ± 2.86  18.27 ± 5.08
IL-6    16,136.96 ± 2,706.56  19,075.01 ± 2,602.4  17,029.73 ± 6,587.89  12,809.33 ± 4,294.63
TNF-α 1,022.25 ± 97.82 1,064.88 ± 92.41 1,125.49 ± 260.02 1,050.22 ± 128.63
IL-10   1,310.1 ± 52.88   1,558.11 ± 223.29   1,642.48 ± 105.25*  1,711.51 ± 100.9†
*p < 0.05, †p < 0.01, n = 5. 
Fig. 6. Effect of carbon black (CB) on platelet activity in rats of the exposure groups. EC: control, EL: low, EM: middle, EH: high. n = 5.
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generating a higher concentration enlarged the particle size in 
our experimental system (data not shown), for unknown rea-
sons. Therefore, 106 particles/cm3 was set as the highest expo-
sure concentration. Several studies have reported the generation 
of CBPs for inhalation exposure. Ma-Hock et al. employed a 
dust feeder to generate CBPs with a median particle size of 150 
nm in scanning mobility particle sizer and 400 nm in optical 
particle counter [7]. Renwick et al. reported an average particle 
size of 260.2 nm [8], and 0.6-0.9 µm CBPs were generated by 
Elder et al. [9]. Recently, Niwa et al. succeeded in generating a 
relatively smaller particle size ranging from 188 to 122 nm at a 
high CB concentration of 1.57 ± 0.4 × 104 particles/cm3 [10]. 
Hence, our work is the first study to successfully generate ul-
trafine CB with a mean particle size of 83.3-87.9 nm at a high 
number concentration of  up to 4.2 × 106 particles/cm3. This 
allowed us to investigate the biological effect of nano-CBPs.
The potential for the respiratory exposure of CB to induce 
pulmonary inflammation has remained controversial. CB is 
generally regarded as less toxic than other types of  carbon-
based PM such as single walled carbon nanotube and residual 
oil fly ash which were reported to elicit toxicity and inflam-
mation in the lungs [11]. Indeed, Li et al. failed to detect the 
increment of  LDH in BALF from the animals treated with 
CBPs intratracheally [12]. On the other hand, the intratracheal 
instillation of CBPs at relatively larger amounts of 125 and 500 
µg/kg significantly elevated LDH in BALF in experimental 
animals [8]. In our experiment, the inhalation of CBPs with a 
diameter of 83.3-87.9 nm neither induced toxicity of the lungs 
nor elicited pulmonary inflammation up to the concentration 
of 4.2 × 106 particles/cm3. Intriguingly, the IL-10 level was el-
evated in BALF with nano-CBPs in a concentration-dependent 
manner whereas most of  the tested cytokines did not change 
(Table 5). We could not elucidate why only the IL-10 level was 
Table 6. Serum biological values of rats
Control Low Middle High
WBC    4.92 ± 0.57    5.41 ± 1.04   6.39 ± 1.33   5.14 ± 0.82
RBC    8.38 ± 0.44    8.48 ± 0.36   8.74 ± 0.41   8.66 ± 0.49
PLT 958.57 ± 67.37 912.00 ± 37.88 989.86 ± 76.00 906.00 ± 81.28
All values are expressed as mean ± standard deviation.
WBC: white blood cell count (103/mm3), RBC: red blood cell count 
(106/mm3), PLT: platelet (103/μ3).
Fig. 7. Effect of carbon black on contraction and relaxation of blood 
vessels in rats of the exposure groups. EC: control, EL: low, EM: middle, 
EH: high. n = 5.
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increased; however, histological analysis suggested that nano-
CBPs do not induce inflammatory responses in the respiratory 
system despite the increase in IL-10. Further study will be 
needed to elucidate the consequence of IL-10 elevation.
Most of  the studies investigating ultrafine or nano-sized 
materials revealed that inhaled particles can enter into the cir-
culation directly and may exhibit biological activity, as indeed 
was the case with CB [13]. Therefore, it is reasonable to assume 
that CB may translocate into the blood and thereby affect the 
functions of  the circulation system. To test this hypothesis, 
we examined platelet aggregation, plasma coagulability and 
vasomotor function, but none was altered by CBP exposure. 
These results suggest that inhaled nano-CBPs have minimal 
effect on hemostatic and vascular functions. At present, we 
could not clarify whether this is because nano-sized CB does 
not move into circulation or because nano-CB is inert and can-
not therefore induce any functional changes. It is also possible 
that quantity of nano-CBPs reaching circulation is not enough 
to affect physiological function of circulatory system.  In any 
case, it seems clear that the inhalation of nano-CBPs, up to a 
substantial exposure level of 106 particles/cm3, does not criti-
cally damage the circulatory functions tested in our study.
To summarize, we successfully generated nano-CBPs, and 
the exposure of these particles to rats did not induce any toxic-
ity or inflammatory response in the lungs or make any func-
tional alteration of  the hemostatic and vasomotor activities. 
The exposure protocol established in this study can be a useful 
and reliable method to investigate the biological or toxicologi-
cal effect of inhaled nano-CBPs.
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